At FutureLink Barcelona 2019, leaders from across the life sciences industry gathered to reimagine the future of healthcare delivery and explore how data can drive innovation, transform business operations and improve patient outcomes using serialised data.
Supply Chain
With the Falsified Medicines Directive (FMD) and Drug Supply Chain Security Act (DSCSA) deadlines now passed, the conference discussed how companies can realise the benefits of their serialisation investments.
Over the conference, we spoke to one of the keynote speakers at the event, Carlos Ruiz Martinez, pharma operations leader at Almirall and asked him a few questions about how companies are coping with global regulations and how he thinks the industry will change in the coming years.